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ABSTRACT

701 Welch Road, Suite 3301
Palo Alto, CA 94304

Biomedical Application Teams are funded by the National
Aeronautics and Space Administration for the purpose of
applying aerospace technology to the solution of significant
problems in biomedical research and clinical medicine. The
Team at Stanford University Medical School is part of the
Division of Cardiology and participates in all phases of the
technology transfer process including: identification of
significant biomedical problems, matching them with appro
priate aerospace solutions, testing the new technology in the
laboratory and clinical environment and finally, being the
link to the medical device industry for commercially pro
ducing the technology. The underlying philosophy and gen
eral approach by which aerospace engineering and scientific
expertise can be used to solve biomedical instrumentation
problems is discussed. The methods by which the Teams
accelerate the diffusion of new technology from aerospacerelated research to medical applications are reviewed. Speci
fic examples of successful transfers are presented to illustrate
the many phases of the technology transfer process and the
need for a multidisciplinary, team approach. Innovative
technology derived from aerospace-related research is pro
viding the physician with new and better instrumentation for
medical research and patient care.

2. Research Triangle Institute
P.O. Box 12194
Research Triangle Park, NC 27709
3. University of Wisconsin
1500 Johnson Drive
Madison, Wl 53706
The Stanford BATeam began in June, 1971 and is part of the
Division of Cardiology at the Stanford University School of
Medicine, Stanford, CA. The Team consists of scientists,
physicians, and engineers who work in close cooperation
with the NASA Field Centers and in particular, with the bio
medical and engineering personnel at the NASA-Ames
Research Center, Moffett Field, CA. Initially, emphasis was
placed on the solution of important problems in the diagno
sis and treatment of cardiovascular diseases. Consequently,
applications addressed instrumentation problems in electrocardiography, cardiac catheterization, biomedical electrodes,
and ultrasonic cardiac imaging. More recently, the Team has
found applications for space technology in a wide range of
medical specialties including: neurosurgery, orthopedics,
communicative disorders, pediatrics, radiology, ophthalmol
ogy, and neurology.

INTRODUCTION
In the Space Act of 1958 Congress directed NASA to "pro
vide for the widest practical and appropriate dissemination of
information concerning its activity and the results thereof." '
Following this mandate, NASA established a Technology
Utilization Program to apply its technology to problems in
such diverse areas as industry, transportation, communica
tions, housing, and energy. Because of the special need "to
bridge" the gap between engineering and medicine, NASA
subsequently established Biomedical Applications Teams
(BATeams) affiliated with major medical institutions. There
are BATeams located at the following institutions:
1. Stanford University School of Medicine,
Cardiology Division

Luke F. Brennan, M.S.B.M.E.
Biomedical Engineer
Biomedical Applications Team*

THE TECHNOLOGY TRANSFER PROCESS
The overall goal of the Biomedical Technology Transfer
Program is the solution of significant technological problems
which are impeding progress in medical research and clinical
practice. To reach this goal, the following intermediate
objectives must be met:
1. Identification of significant medical problems
amenable to technological solution.
* Stanford University School of Medicine
Stanford, CA 94305
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2. Selection of the appropriate NASA technology which
may have been developed for other purposes.
3. Adaptive engineering to meet the medical
requirements.
4. Demonstration of technical and medical feasibility.
5. Commercial transfer to the medical device industry
to permit widespread utilization.
PROBLEM IDENTIFICATION AND SELECTION
The term "technology/' as used here, is broadly defined to
include the hardware, software, and engineering expertise
which has been an integral part of aerospace research and
development. Technology includes scientific instruments,
unique test facilities, computer programs, technical reports,
research results, and new materials developed for special
aerospace applications. Of greater importance, however, are
the human resources (the scientific and engineering expertise,
and spirit of cooperation) which permit the free exchange of
ideas so necessary to the identification and implementation
of solutions.
There are many ways in which technology developed through
the space program can be applied or transferred to solving
biomedical problems. No single approach to transferring
technology is applicable in all situations; however, the
following is the general approach most frequently used by
BATeams.
A team representative (physician, engineer or biomedical
engineer) confers with the medical scientist or clinician who
has requested assistance with a specific technical problem. At
this initial meeting a Problem Statement is developed which
includes the following: the general medical background;
specific technical needs; engineering constraints and specifi
cations; facilities, staff, and funding available for imple
mentation; existing solutions and their deficiencies; and
selected literature references. The Problem Statements are
then evaluated by the Team to ensure that they meet the
following criteria:
A. There is no satisfactory solution currently available
from industry.
B. The problem can be specified in terms which made it
amenable to a solution derived from aerospace
technology.
C. Solution of the problem would, make a significant
contribution to medical research or clinical practice.

If a problem meets these criteria, the next step is to identify
NASA hardware, software, or engineering expertise relevant
to the problem. First, a computer search of the aerospace
data banks, which may be accessed through one of NASAs
six Industrial Applications Centers, is performed. These on
line computer searches utilize the NASA Scientific and
Technical Information Facility in Maryland which contains
more than a million documents, articles, and translations ab
stracted from the scientific and technical aerospace reports,
the international aerospace abstracts, computer program
abstracts, tech briefs, and many other publications. Next,
the Team contacts NASA personnel who have done research
or project work related to the specific problem requirements.
These NASA engineers are contacted through the Field
Centers' Technology Utilization Offices. The problem state
ment, formulated during the initial interview, is circulated
among scientists and engineers who have been selected by the
BATeam, the Technology Utilization Officers at the individ
ual field centers, or by program managers at NASA Head
quarters in Washington^D.C.
All potentially relevant technology that is identified by these
searches is evaluated by the BATeam to determine whether a
promising solution has been found. These potential solutions
are then presented to the problem originator along with the
supporting NASA data and documents.
Yet another approach to transferring NASA technology to
medicine is to identify an instrument already developed for
an aerospace application and to find a new use for it in the
medical field. Usually significant modification and human
factors engineering are needed to satisfy the requirements for
use in the medical application. Assuming that an appropriate
application can be found, this approach has the following ad
vantages: technical feasibility has already been demonstrated
and only the medical feasibility need be evaluated; since the
instrument already exists, much time has been saved in pro
totype development; and it is possible that the manufacturer
of the instrument for the specialized aerospace application
will also be interested in making it commercially available for
medical applications.
ADAPTIVE ENGINEERING
Instrumentation originally designed for the space program
usually needs to be modified or re-engineered to optimize it
for its new application in the research laboratory or clinical
setting. The problem originator often requires engineering
support to make these modifications. The Team assists the
medical investigator in obtaining funding from either NASA,
a potential manufacturer, or one of the federally funded
health agencies.
DEMONSTRATION OF FEASIBILITY

D. There is sufficient interest on the part of the medical
device industry to anticipate their early involvement
and cost-sharing in either the feasibility demonstration
or later developmental stages.

Demonstration of technical and medical feasibility for any
new instrument is costly and time-consuming. The NASA
Technical Utilization (TU) program alone cannot fund
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clinical or preclinical trials; and therefore, the Team and the
problem originator must solicit support from the National
Institutes of Health, the Rehabilitation Services Administra
tion, the Veterans Administration, or the medical device
industry. For example, if NASA technology is being utilized
in a new instrument for diagnosing a cardiac abnormality,
then the medical investigators would seek support from the
National Heart, Lung, and Blood Institute within the Nation
al Institute of Health (NIH) for laboratory studies and
clinical trials. In addition to broadening the source of fund
ing for a given project, the requirement for support by a nonNASA governmental agency helps to ensure that the tech
nology being transferred will meet a widely perceived need.
After successful clinical trials, presentations are made at
major medical and engineering symposia and published in
biomedical journals in order to gain acceptance of the new
technology by the medical community. Even when each of
these objectives has been met, the new biomedical device
cannot achieve widespread use until it becomes commercially
available.

EXAMPLES OF COMPLETED
MEDICAL TECHNOLOGY TRANSFERS
The following three exafnples illustrate both the scope of the
Stanford BATeam program, and the evolution of technology
transfer from the problem definition stage to the complete
commercial transfer. In each example the medical back
ground and need, the NASA technological solution, and the
current status of the transfer are described.
1. Biomedical Electrodes
A biomedical electrode is an electrically conductive interface
for the recording of physiological signals. The most familiar
examples of biomedical electrodes are the plates and suction
cups used in recording a routine electrocardiogram. Similarly,
adhesive-backed surface electrodes are used extensively in
monitoring the cardiac and respiratory signals of patients in
hospital intensive care units. The seemingly simple task of
obtaining dependable long-term electrical signals from
patients has proven to be a difficult bioengineering problem.
Haslam and Bruner have reported that half of the monitoring
system failures in the typical hospital are the result of
difficulties with leads and electrodes.^

COMMERCIALIZATION
Widespread use of a device resulting from the Technology
Transfer Program requires the assistance of the medical
device industry. Before a new technology can achieve com
mercial success, it must meet the following criteria:
1. The NASA technological solution must provide an
improvement in medical treatment or diagnosis.
2. The solution must provide a reduction in health care
cost or a significant improvement in the quality of care.
3. The medical market must be large enough to warrant
the necessary capital risk by industry.
4. The device must be manufacturable at a cost which
will permit penetration into the market.
5. The identified manufacturer must be able to bear most
of the future developmental costs.
The initial step in the commercialization process is to de
termine the potential market for the new device. Market data
is accumulated by contacts with potential manufacturers and
through a formal market survey conducted by the Illinois
Institute of Technology Research Institute, which is under
contract to NASA for this purpose. If the market survey is
favorable, proposals are solicited from manufacturers to pro
ceed with further development and commercialization. The
Team then selects the most suitable commercial manufac
turer based on evidence of understanding of the technical
problems, previous experience with the requisite technologies,
availability of resources for quality control, and large-scale
manufacturing and marketing resources.

In order to stimulate advances in electrode technology, the
BATeam held a conference in 1973 attended by 200 special
ists in representing academia, government, industry, and
medicine. The proceedings of this conference were edited
and published^ and provided a comprehensive review of
the subject, clarifying the needs and deficiencies in present
technology, as well as suggesting improvements and stimulat
ing further research to advance the state of electrode tech
nology. The Conference stimulated changes in the types of
materials and designs used in electrode manufacture. One
electrode manufacturer subsequently developed and market
ed a low-profile, soft, conformable surface electrode based
on a presentation made by a NASA engineer.
The elec
trode is made by impregnating an elasticized nylon mesh
cloth with conductive silver particles and is backed with an
adhesive silicon sponge rubber disc (Figure 1). A tab of the
conductive nylon is then attached to a lead wire with a
conductive epoxy. The manufacturer who attended the
NASA-sponsored conference has been marketing the elec
trode since 1975. Because these electrodes are soft and easily
conform to the body surface, they permit continuous moni
toring with minimal patient discomfort. This type of elec
trode has also been applied in rehabilitative medicine.
2. Biotelemetry for Pediatric Gait Analysis
Cerebral palsy is a crippling neurological disease which
manifests itself in early childhood. It results in varying
degrees of muscular spasticity and loss of coordination. The
inappropriate muscular contractions and loss of coordination
frequently result in severe walking impairment. Although
there is no cure for the disease, accuate diagnosis of the in
dividual patient's gait abnormality is essential to the per
formance of corrective orthopedic surgery.
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Normal ambulation is a complex activity requiring the co
ordinated contraction and relaxation of many individual
muscle groups in the legs. In analyzing walking abnormalities,
physical therapists make use of the electromyographic
(EMG) signals associated with muscle contraction. In adults
and large children it is feasible to attach surface electrodes
over the muscles to be examined and run wires from those
electrodes to a recording device. Children with cerebral
palsy, who are candidates for corrective surgery, are fre
quently only 3-4 years old and a bundle of wires trailing
behind the child may, itself, affect his already unstable gait
pattern. In addition, since the child is aware of being moni
tored by the physician or therapist, he may modify his usual
walking pattern and give a false impression of his gait ab
The problem posed to NASA, therefore, was to
normality.
devise a monitoring system which would allow the recording
of the EMG signal in small children with cerebral palsy with
out interfering, either physically or psychologically, with
their natural ambulatory pattern.
The NASA solution is represented diagrammatically in
Figure 2. Multiple individual radio transmitters (decorated as
lady-bugs) are utilized. The transmitter circuit was designed
by a NASA engineer to minimize external electromagnetic
interference, maximize battery life, and provide a wide band
width for both research and clinical applications. This
approach provided the following advantages over earlier
instrumentation:
1 . The size and weight of the transmitters were
more suitable for evaluating younger children.
2. Use of individual transmitters simplified
instrumenting the patient, thus reducing
the time required for the examination.
3. The individual, self-contained transmitters
eliminated earlier problems with cables and
connectors and permitted adding or subtracting
units as needed for the individual patient.
An 8-channel system is now in use at the Children's Hospital
at Stanford, Palo Alto, CA. Up to six channels of EMG data
can be recorded simultaneously. The other two channels are
used for foot switch information, indicating either the swing
or weight-bearing phase of gait. The system is now being
manufactured commercially and a design which makes in
creased use of integrated circuitry to further reduce size and

necessitates continuous and accurate monitoring of ICP. The
measurement of ICP is particularly useful in deciding which
medical and surgical therapies are appropriate. The most
commonly used technique for monitoring ICP utilizes a fluidfilled catheter in direct communication with the cerebrospinal fluid and coupled externally to a pressure transducer.
One of the problems associated with this technique is that
the catheter provides a direct pathway for brain infection,
limiting the monitoring period to at most a few days.
In cooperation with the Departments of Neurosurgery and
Anesthesiology at Stanford University Medical School,
NASA-Ames Research Center engineers have designed an
epidural pressure transducer/transmitter for continuous
monitoring of ICP. The pressure transducer is adapted from a
design originally used by NASA for the measurement of air
pressure over the wings of experimental aircraft during wind
tunnel tests. Likewise, the inductively-powered biotelemetry
electronics are based on developments within the NASA Life
Sciences Program for monitoring man and animals in space.
As shown in Figure 3, the neurosurgeon inserts the ICP
transducer/transmitter through a small hole in the skull and
secures it in a mounting fixture. The transmitter is locked in
place so that its transducer diaphragm is in direct contact
with the dura, a protective membrane which surrounds the
brain. The scalp is sutured closed over the unit so that there
is no direct pathway for infection. Changes in ICP are con
verted into a frequency and transmitted to an external
receiver (not shown in the figure).
Clinical trials are in progress at the Stanford University. The
ICP monitor is inserted at the end of a neurosurgical pro
cedure and patients are monitored continuously in the
Intensive Care Unit. The approach has proven to be safe and
reliable gnd a medical device manufacturer has been licensed
by NASA to produce the next generation system for wide
spread clinical use.
ADDITIONAL BIOMEDICAL EXAMPLES
OF TECHNOLOGY TRANSFER
Each of the preceding examples are completed technology
transfers which have already reached the commercialization
stage. The following are short descriptions of additional
Stanford BATeam projects which are in the earlier stages of
transfer.

weight is under consideration.

1. Versatile Portable Speech Prosthesis

3. Intracranial Pressure Monitorying.

This is a communications device for use in rehabilitative
medicine by nonvocal, handicapped patients. The system
consists of a user interface module, a microprocessor-based
computer system, and a synthesized speech output device.
Extensive use is made of aeronautical communications
technology developed by NASA during investigations of
synthesized speech in advanced aircraft. The device has been
designed to minimize training time, to permit the user to

In cases of head -trauma, brain tumor, cerebral infection, and
hydrocephalus, the pressure Inside the head, or intracranial
pressure (ICPLcan become dangerously elevated. Elevation
in ICP can lead to reduced blood flow to the brain, resulting
in irreversible damage or death within a few minutes. Opti
mal management of the brain-injured patient, therefore,
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develop his own vocabulary, to adapt to a wide range of user
physical disabilities, to permit rapid sentence construction,
and to provide improved speech intelligibility. The system
will be used initially with wheelchair-confined cerebral palsy
patients at the Children's Hospital at Stanford; however, the
versatility of its design makes it potentially applicable to
patients with multiple sclerosis, Parkinson's disease, muscular
dystrophy, and stroke.

5. Liquid Circulating Garments
Temperature-regulated garments were developed for astro
nauts to permit them to withstand the temperature extremes
associated with extravehicular activity during spaceflight.
The following medical applications have been proposed and
are currently under evaluation:
1. Elevation of body temperature in the treatment of
metastatic cancer, both alone and in conjunction
with chemotherapy.

2. Radiographic Spatial Frequency Multiplexing
This is an x-ray filtering and decoding technique for enhanc
ing the contrast of selected body tissues and organs. The
technique holds promise for imaging soft tissue tumors
otherwise hidden by overlying bone as well as permitting ex
amination of internal organs using peripheral injections of
low doses of contrast materials. The x-ray decoding system is
an application of NASA technology developed for the Earth
Resources Technology Satellite. At present, only laboratory
animal studies have been performed; it is anticipated that
patient studies will commence this year.

2. Surface cooling prior to cooling by cardiopulmonary
bypass for certain types of heart and brain surgery.
3. Lowering of body temperature in patients with
diffuse brain injury to reduce metabolic rate and
oxygen requirements.
4. Surface cooling of the breasts prior to thermography
to aid in the detection of breast cancer.

3. Pediatric Roentgen Densitometry
The Roentgen Densitometer is a diagnostic x-ray device de
signed for screening newborn infants for intracardiac shunts.
The system consists of a standard x-ray source coupled to an
array of solid-state gamma detector diodes which were
developed during NASA-sponsored solar cell research for
powering satellites. When an infant is born with a heart
murmur or develops cyanosis, it may be difficult to tell
whether he has a surgically correctable congenital heart
defect or some other nonsurgical problem. To resolve this
diagnostic dilemma, cardiac catheterization may be necess
ary. Cardiac catheterization not only requires elaborate instru
mentation and technical personnel, but involves some risk to
the infant. In contrast, roentgen densitometry, which re
quires only the peripheral injection of a small amount of
radiopaque material, can be performed in the newborn
nursery with far less risk and expense. Used as a screening
device, it could reduce the number of catheterizations per
formed. Studies in over 50 infants using a prototype device
were successfully completed and three second-generation
densitometers are being fabricated for evaluation at major
university cardiology departments.
4. Nanophor
This is a laboratory instrument which uses an electric field
for separating and identifying medically important serum
proteins. This instrument's initial development was funded in
part by NASA for use in analyzing the serum proteins of
Apollo astronauts. It is an improvement over existing electrophoresis instruments in that it permits analysis of nanogram
quantities of serum and incorporates a multiple-sample appli
cator to speed up the analysis and improve the accuracy of
the test. NASA has recently granted a license for the com
mercial manufacture of this new instrument.

5. Applications in such rare diseases as hyperkeratosis
and "burning limb" syndrome.
6. Regulation of infant body temperature during surgery.
The NASA garments contain flexible heat transfer panels
made of a polymer inscribed with tiny channels through
which cooled or heated water is circulated.
6. Noninvasive Determination of Bone Properties
Stanford University engineers in collaboration with NASA
scientists have developed a mechanical device for measuring
the driving point impedance of bone. The development of
this new instrument grew out of NASAs interest in deter
mining bone demineralization caused by the zero gravity of
space flight. In performing the test, a vibrating probe is
placed in contact with the subject's forearm and the force
and displacement of the bone are analyzed and used to calcu
late bending ridigity and axial buckling load index, that is,
the load or weight which the bone can support without
fracturing. The device incorporates a microprocessor which
permits performance of five tests complete with computer
print-out in approximately 10 seconds. Preliminary tests in
the Orthopedic Clinic have shown that the instrument can
provide a useful measure of bone strength, and can readily
detect differences between an injured and uninjured limb.
Although further data are being obtained on the reproducibility and sensitivity of the test, the instrument promises
to be useful in diagnosing fractures, and following the course
of fracture healing, as well as in evaluating osteoporosis, a
common bone disease of older patients.
CONFERENCES AND PUBLICATIONS
In addition to its daily activities in transferring technology to
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the solution of particular biomedical problems, the Stanford
BATeam, sponsored by NASA, has conducted both national
and international conferences addressing broader areas of
biomedical instrumentation. The first of these conferences,
held in 1973, was entitled "Biomedical Electrode Tech
nology: Theory and Practice/' This was followed in 1975 by
"Cardiovascular Imaging and Image Processing - Ultrasound,
Angiography, and Isotopes/7 In 1976 the 'Third Inter
national Symposium on Biotelemetry" was held on the
West Coast, and most recently, the BATeam hosted the
"Noninvasive Cardiovascular Measurements Conference" in
September 1978. The proceedings of each of these confer
ences have been compiled, edited, and published. 3' 8, 9, 10
These conferences highlight NASA technological develop
ments and provide a review of related advances in biomedical
instrumentation, as well as a forum for evaluating com
petitive technologies, and identifying those areas where
improvements are needed. In general, such conferences
provide a means by which ". . . the technologist and the user
can educate each other as to what each might be able to do
and ... to reach a point where some technology can be
transferred."^

— A lack of appreciation of the technical difficulties and
financial risks involved in commercially developing new
technology
Though each of these problems is complex and involves
diverse groups with their own special interests, collaborative
solutions must be found to achieve the common goal of more
efficient use of medical resources.

CONCLUDING REMARKS
Although technology from one field can become transferred
or reapplied to a new discipline and for a new application by
the slow, natural process of diffusion, successful transfer is
frequently hindered by language, economic, and regulatory
barriers. The transfer of technology, however, can be acceler
ated through multidisciplinary and systematic efforts by Bio
medical Applications Teams which act as catalysts in the
application of NASA technology to the solution of biomed
ical problems.
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Figure 1. Flexible Biomedical Electrodes Being Applied for Ambulatory
Electrocardiogram Recording
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